Cowen Downgrades Constellation Pharmaceuticals (CNST) to Market Perform
Tweet
Share
E-mailGet Alerts CNST Hot Sheet
Price: $33.99 --0%
Rating Summary:
3 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
3 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Cowen analyst Marc Frahm downgraded Constellation Pharmaceuticals (NASDAQ: CNST) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Constellation Pharmaceuticals click here. For more ratings news on Constellation Pharmaceuticals click here.
Shares of Constellation Pharmaceuticals closed at $33.57 yesterday.
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- Citizens Downgrades Accelerant Holdings (ARX) to Market Perform
- UBS Downgrades ASX Limited (ASX:AU) (ASXFY) to Neutral
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
